Literature DB >> 6155424

Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype.

V Agnello, A Arbetter, G Ibanez de Kasep, R Powell, E M Tan, F Joslin.   

Abstract

Cross-reactivity of a monoclonal rheumatoid factor with an antigen present on IgG and DNA-nucleoprotein was demonstrated, and evidence presented that the combining site of the antibody was involved in the reaction. The antigen on the DNA-nucleoprotein was shown to involve both DNA and histone fraction H2A + H2B and was trypsin sensitive. The relative binding affinity of the antibody appeared to be greater for IgG than the DNA-histone antigen. Similar polyclonal cross-reactive rheumatoid factors were found in a variety of diseases. A high incidence was found among patients with rheumatoid arthritis and mixed connective tissue disease. None were detected in patients with systemic lupus erythematosus and idiopathic cryoglobulinemia. Studies on one representative isolated polyclonal rheumatoid factor demonstrated the same reactivity with DNA-histone H2A + H2B as the monoclonal antibody. Cross-idiotype studies using antigen-binding inhibition methods demonstrated the same cross-idiotype on the polyclonal and the monoclonal rheumatoid factor which reacted with DNA-histone. This cross-idiotype was shown to be distinct from the cross-idiotypes previously demonstrated on monoclonal IgM proteins with anti-gamma-globulin activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155424      PMCID: PMC2185879          DOI: 10.1084/jem.151.6.1514

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Purification of the first component of human complement and its subunit C1 esterase.

Authors:  D H Bing
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

2.  Antinuclear antibodies and nuclear antigens in rheumatoid synovial fluids.

Authors:  P Robitaille; N J Zvaifler; E M Tan
Journal:  Clin Immunol Immunopathol       Date:  1973-04

3.  Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus.

Authors:  F Paronetto; D Koffler
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

4.  Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures.

Authors:  A G Plaut; T B Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  1970-02       Impact factor: 11.205

5.  Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.

Authors:  A Gabriel; V Agnello
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

6.  Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei.

Authors:  K Hannestad; A Johannessen
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Structure of antibodies with shared idiotypy: the complete sequence of the heavy chain variable regions of two immunoglobulin M anti-gamma globulins.

Authors:  J D Capra; J M Kehoe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

8.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  Homogenous rabbit 7S anti-IgG with antibody specificity for peptidoglycan.

Authors:  V A Bokisch; J W Chiao; D Bernstein; R M Krause
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies.

Authors:  M C Michaelides; H N Eisen
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  51 in total

Review 1.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 2.  Idiotypes and autoimmunity.

Authors:  D K Male
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

Review 3.  Rheumatoid factor cross idiotypes.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Complete amino acid sequence of variable domains from two monoclonal human anti-gamma globulins of the Wa cross-idiotypic group: suggestion that the J segments are involved in the structural correlate of the idiotype.

Authors:  D W Andrews; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

Review 5.  Molecular basis for cryoprecipitation.

Authors:  A C Wang
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors.

Authors:  J C Mason; P J Venables; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

7.  Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

Authors:  R L Rubin; R S Balderas; E M Tan; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

8.  Cellular localization of rheumatoid factor idiotypes.

Authors:  V R Bonagura; H G Kunkel; B Pernis
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.

Authors:  L Cosgrove; F Alderuccio; B H Toh; J Pedersen; A Holliday; I McKenzie
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

10.  Serological and genetic characterization of a human monoclonal immunoglobulin G anti-DNA idiotype.

Authors:  M R Ehrenstein; C M Longhurst; D S Latchman; D A Isenberg
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.